Carbidopa Levodopa
Carbidopa Levodopa is the gold-standard therapy for Parkinson's disease. Levodopa is converted into dopamine in the brain to help restore movement control. Carbidopa is a decarboxylase inhibitor that prevents levodopa from breaking down in the bloodstream before it reaches the brain, reducing side effects such as nausea.
Dosage by Body Weight
Dosage must be highly individualized and titrated slowly under strict medical supervision. Usually started at a low dose (e.g., 25/100 mg three times daily) and adjusted based on clinical response. Take at least 30 minutes before or 1 hour after high-protein meals to ensure optimal absorption.
- Body Weight
- Below 5 kg
- Dose
- Not indicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy in pediatric patients of this weight have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not indicated
- Frequency
- Not applicable
- Tracking Notes
- Parkinson's disease does not occur in this population. Use only under highly specialized pediatric neurology guidance for rare genetic metabolic conditions.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- As directed by a specialist
- Tracking Notes
- Extremely rare pediatric indications (e.g., Dopamine-Responsive Dystonia). Specialist supervision is required.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- As directed by a specialist
- Tracking Notes
- Extremely rare pediatric indications (e.g., Segawa's disease). Dose must be meticulously titrated by a pediatric neurologist.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- As directed by a specialist
- Tracking Notes
- Extremely rare pediatric indications. Requires close monitoring of motor symptoms and side effects.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not indicated | Not applicable | Safety and efficacy in pediatric patients of this weight have not been established. |
| 5-7 kg | Not indicated | Not applicable | Parkinson's disease does not occur in this population. Use only under highly specialized pediatric neurology guidance for rare genetic metabolic conditions. |
| 8-10 kg | Not routine | As directed by a specialist | Extremely rare pediatric indications (e.g., Dopamine-Responsive Dystonia). Specialist supervision is required. |
| 11-15 kg | Not routine | As directed by a specialist | Extremely rare pediatric indications (e.g., Segawa's disease). Dose must be meticulously titrated by a pediatric neurologist. |
| 16-20 kg | Not routine | As directed by a specialist | Extremely rare pediatric indications. Requires close monitoring of motor symptoms and side effects. |
Formulation
Purpose
Used to treat symptoms of Parkinson's disease and Parkinson-like conditions, such as tremors, muscle stiffness, and difficulty moving.
Generic Name
Carbidopa and LevodopaBranded Drug Names
Carbidopa Levodopa is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.